BLAS VILLA: Open Payments
NPI 1063053072 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 13 payments from 11 companies in 2025. Trend: 2023 $2,160 · 2024 $1,883 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $249 |
| Janssen Biotech, Inc. | 2 | $222 |
| Lilly USA, LLC | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Mallinckrodt Hospital Products Inc. | 1 | $124 |
| Aimmune Therapeutics, Inc. | 1 | $122 |
| Stryker Corporation | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $118 |
| Phathom Pharmaceuticals, Inc. | 1 | $112 |
| Grifols USA, LLC | 1 | $46 |
Products named: TREMFYA, OMVOH, IQIRVO, REZDIFFRA, TERLIVAZ, Bylvay, ZENPEP, CLOTTRIEVER BOLD CATHETER.
Industry payments across TX — which companies pay providers there.
